糖尿病患者使用磺脲类药物治疗时，SUR受体活性与低血糖发生率及心血管死亡率的关系 - Suppr

SUR receptor activity vs. incidence of hypoglycaemia and cardiovascular mortality with sulphonylurea therapy for diabetics.

作者信息

Tayek J

出版信息

Diabetes Obes Metab. 2008 Nov;10(11):1128-9; author reply 1129-30. doi: 10.1111/j.1463-1326.2008.00928.x. Epub 2008 Jul 29.

DOI:10.1111/j.1463-1326.2008.00928.x

PMID:18671799

Abstract

摘要

相似文献

SUR receptor activity vs. incidence of hypoglycaemia and cardiovascular mortality with sulphonylurea therapy for diabetics.

Diabetes Obes Metab. 2008 Nov;10(11):1128-9; author reply 1129-30. doi: 10.1111/j.1463-1326.2008.00928.x. Epub 2008 Jul 29.

Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channels.

Nature. 1996 Feb 8;379(6565):545-8. doi: 10.1038/379545a0.

ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.

N Engl J Med. 2006 Aug 3;355(5):507-10. doi: 10.1056/NEJMe068142.

[Sulfonylurea drugs for type 2 diabetes].

Nihon Rinsho. 2002 Sep;60 Suppl 9:339-45.

Lipids modulate ligand binding to sulphonylurea receptors.

Br J Pharmacol. 2005 Aug;145(7):907-15. doi: 10.1038/sj.bjp.0706252.

[Ontogeny of sulphonylurea-binding regulatory subunits of K(ATP) channels in the pregnant rat myometrium].

Acta Pharm Hung. 2011;81(3):101-7.

[Sulfonylurea receptors].

Duodecim. 1989;105(19):1578-80.

[Glimepiride].

Nihon Rinsho. 2002 Sep;60 Suppl 9:351-6.

Understanding protein-sensitive hypoglycemia.

J Pediatr. 2006 Jul;149(1):6-7. doi: 10.1016/j.jpeds.2006.04.062.

[ATP-sensitive potassium channel--sulfonylurea receptor].

Nihon Rinsho. 1997 Oct;55 Suppl:458-62.

引用本文的文献

[Diabetic kidney disease (update 2023) : Position paper of the Austrian Diabetes Association and the Austrian Society for Nephrology].

Wien Klin Wochenschr. 2023 Jan;135(Suppl 1):182-194. doi: 10.1007/s00508-022-02147-3. Epub 2023 Apr 20.

[Diabetic kidney disease (Update 2019) : Position paper of the Austrian Diabetes Association and the Austrian Society for Nephrology].

Wien Klin Wochenschr. 2019 May;131(Suppl 1):151-163. doi: 10.1007/s00508-018-1425-x.

[Diabetic kidney disease - Update 2016].

Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S85-96. doi: 10.1007/s00508-016-0992-y.

A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study.

Vasc Health Risk Manag. 2014 May 28;10:319-26. doi: 10.2147/VHRM.S64038. eCollection 2014.

Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan.

Vasc Health Risk Manag. 2014;10:15-24. doi: 10.2147/VHRM.S54585. Epub 2013 Dec 24.

The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.

Diabetes Care. 2010 Jun;33(6):1224-9. doi: 10.2337/dc10-0017. Epub 2010 Mar 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

SUR receptor activity vs. incidence of hypoglycaemia and cardiovascular mortality with sulphonylurea therapy for diabetics.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献